Nexien BioPharma, Inc.

0.0120+0.00 (+0%)

Oct 28, 4:00:00 PM EDT · OTC Markets OTCPK · NXEN · USD

Upcoming Earnings

Report date

Key Stats

Market Cap

849.27K

P/E (TTM)

Basic EPS (TTM)

0.00

Dividend Yield

Recent Filings

10-Q

5/14/25May 14, 2025

10-Q

2/14/25Feb 14, 2025

10-Q

11/18/24Nov 18, 2024

10-K

10/22/24Oct 22, 2024

10-Q

5/15/24May 15, 2024

About

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

CEO

Mr. Richard S. Greenberg

IPO

11/29/2017

Website

https://www.nexienbiopharma.com

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic